Theia

Article

Made Scientific and Streamline Bio Launch Early Adopter Program for AI-Driven Cell Therapy Automation

INDUSTRIAL IOT

Made Scientific has been designated as the exclusive contract development and manufacturing organization (CDMO) partner for Streamline Bio's AI-driven robotic manufacturing platform. This partnership aims to accelerate the development of automated workflows in GMP cleanroom environments.

The program will focus on integrating and validating Streamline Bio's technology, targeting improvements in cycle-time optimization and operational scalability for CAR-T manufacturing. The collaboration seeks to provide scalable, cost-effective manufacturing solutions for cell therapies.

Made Scientific and Streamline Bio Launch Early Adopter Program for AI-Driven Cell Therapy Automation
Feb 11, 2026, 6:47 PM

No comments yet. Be the first to share your thoughts!